O006 : C-swift: grazoprevir/elbasvir + sofosbuvir in cirrhotic and noncirrhotic, treatment-naive patients with hepatitis C virus genotype 1 infection, for durations of 4, 6 or 8 weeks and genotype 3 infection for durations of 8 or 12 weeks

Publication | Closed Access

DOI

Citations

References

2015

Year

Fred Poordad, Eric Lawitz, Julio Gutiérrez, Barbara J. Evans, A Howe, H.-P. Feng, J.J. Li, Peggy Hwang, Michael Robertson, Janice Wahl,

Journal of Hepatology

Genotype 3Hepatic DisordersHepatologyHepatitis CViral PersistenceViral HepatitisAntiviral TherapyHepatitisVirologyChronic Viral InfectionInfection ControlAntiviral DrugMedicineEpidemiologyTreatment-naive Patients